Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries

被引:17
|
作者
Chen, Tianhui [1 ,2 ,3 ]
Brenner, Hermann [4 ,5 ,6 ,7 ]
Fallah, Mandi [2 ,5 ,6 ]
Jansen, Lina [4 ]
Castro, Felipe A. [4 ]
Geiss, Karla [8 ]
Holleczek, Bernd [9 ]
Katalinic, Alexander [10 ]
Luttmann, Sabine [11 ]
Sundquist, Kristina [12 ,13 ]
Ressing, Meike [14 ,15 ]
Xu, Leiting [3 ]
Hemminki, Kari [2 ,12 ]
机构
[1] Zhejiang Acad Med Sci ZJAMS, Inst Occupat Dis, GMECPP, Tianmushan Rd 182, Hangzhou 310013, Zhejiang, Peoples R China
[2] German Cance Res Ctr DKFZ, Div Mol Genet Epidemiol, Heidelberg, Germany
[3] Ningbo Univ, Med Sch, Ningbo, Zhejiang, Peoples R China
[4] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[5] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany
[6] Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[7] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
[8] Ctr Early Canc Detect & Canc Registrat, Bavarian Hlth & Food Safety Author, Nurnberg, Germany
[9] Saarland Canc Registry, Saarbrucken, Germany
[10] Univ Lubeck, Inst Canc Epidemiol, Lubeck, Germany
[11] Leibniz Inst Prevent Res & Epidemiol BIPS, Canc Registry Bremen, Bremen, Germany
[12] Lund Univ, Ctr Primay Hearth Care Res, Malmo, Sweden
[13] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[14] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, Mainz, Germany
[15] Canc Registry Rhinerand Paratinate, Mainz, Germany
关键词
second primary cancer; endometrial cancer; cancer registry; etiology; SUBSEQUENT PRIMARY MALIGNANCIES; OVARIAN MALIGNANCY; EARLY; 21ST-CENTURY; SURVIVAL; DATABASE; COHORT; COMMON;
D O I
10.1002/ijc.30930
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Along with the increasing incidence and favorable prognosis, more women diagnosed with endometrial cancer may develop second primary cancers (SPCs). We aimed at investigating risk of SPCs after endometrial cancer in Germany and Sweden to provide insight into prevention strategies for SPCs. Endometrial cancer patients diagnosed at age >= 15 years in Germany during 1997-2011 and in Sweden nationwide during 1997-2012 were selected. Standardized incidence ratios (SIRs), calculated as the ratio of observed to expected numbers of cases, were used to assess the risk of a specific second cancer after endometrial cancer for both German and Swedish datasets. Among 46,929 endometrial cancer survivors in Germany and 18,646 in Sweden, overall 2,897 and 1,706 SPCs were recorded, respectively. Significantly elevated SIRs were observed in Germany for ovarian (SIR51.3; 95% CI: 1.1-1.5) and kidney cancers [1.6 (1.3-1.8)], while in Sweden the SIRs were 5.4 (4.6-6.3) and 1.4 (1.0-1.9), respectively. Elevated risk for second ovarian endometrioid carcinoma was pronounced after early (< 55 years) onset endometrial cancer in Germany [9.0(4.8-15)] and Sweden [7.7 (5.1-11)]. In Germany elevated risks were found for second ovarian endometrioid carcinoma after endometrioid histology of first endometrial cancer [6.3(4.0-9.4)] and for second kidney cancer after clear cell histology of endometrial cancer [4.9 (1.6-11)]. We found exceptionally elevated risk of second ovarian endometrioid carcinoma after endometrial cancer of the same histology or of early onset. Risk for second kidney cancer was also increased, particularly after endometrial cancer of clear cell histology. Cancer prevention strategies should focus on these cancers after endometrial cancer diagnosis.
引用
收藏
页码:2270 / 2280
页数:11
相关论文
共 50 条
  • [31] Second primary oral and pharyngeal cancers in subjects diagnosed with oral and pharyngeal cancer
    Levi, Fabio
    Te, Van-Cong
    Randimbison, Lalao
    Maspoli, Manuela
    La Vecchia, Carlo
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (11) : 2702 - 2704
  • [32] Risk factors for second primary cancer in a prospective cohort of endometrial cancer survivors: an Alberta Endometrial Cancer Cohort Study
    Kokts-Porietis, Renee L.
    O'Sullivan, Dylan E.
    Nelson, Gregg
    Courneya, Kerry S.
    Cook, Linda S.
    Friedenreich, Christine M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2024,
  • [33] Re: Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries
    William B. Goggins
    Cancer Causes & Control, 2008, 19 : 1409 - 1410
  • [34] Re: Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries
    Goggins, William B.
    CANCER CAUSES & CONTROL, 2008, 19 (10) : 1409 - 1410
  • [35] The association between histological subtype of a first primary endometrial cancer and second cancer risk
    Rhoades, Jennifer
    Vetter, Monica Hagan
    Fisher, James L.
    Cohn, David E.
    Salani, Ritu
    Felix, Ashley S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (02) : 290 - 298
  • [36] Second Primary Gynecologic Cancers After Breast Cancer in Turkish Women
    Gulhan, Ibrahim
    Eser, Sultan
    Yakut, Cankut
    Bige, Ozgur
    Ilhan, Enver
    Yildirim, Yusuf
    Saygili, Ugur
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (04) : 648 - 650
  • [37] Relationship between metastasis and second primary cancers in women with breast cancer
    Li, Chaofan
    Liu, Mengjie
    Li, Jia
    Zhao, Xixi
    Wang, Yusheng
    Chen, Xi
    Wang, Weiwei
    Sun, Shiyu
    Feng, Cong
    Cai, Yifan
    Wu, Fei
    Du, Chong
    Zhang, Yinbin
    Zhang, Shuqun
    Qu, Jingkun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Second primary cancers in men with prostate cancer:: An increased risk of male breast cancer
    Thellenberg, C
    Malmer, B
    Tavelin, B
    Grönberg, H
    JOURNAL OF UROLOGY, 2003, 169 (04): : 1345 - 1348
  • [39] Cardiovascular disease in women diagnosed with endometrial cancer
    Galazis, N.
    Mappouridou, S.
    Mavrou, A.
    GYNECOLOGIC ONCOLOGY REPORTS, 2018, 26 : 108 - 108
  • [40] Survival of most commonly diagnosed second primary cancers among adult cancer survivors
    Sung, Hyuna
    Nisotel, Lauren
    Sedeta, Ephrem
    Islami, Farhad
    Jemal, Ahmedin
    CANCER RESEARCH, 2023, 83 (08)